Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Beta-ketothiolase (T2) deficiency is a rare organic aciduria affecting ketone body metabolism and the catabolism of isoleucine and characterized by intermittent ketoacidotic episodes associated with vomiting, dyspnea, tachypnoea, hypotonia, lethargy and coma, with an onset during infancy or toddlerhood and usually ceasing by adolescence.
Features include always present findings: Elevated urinary 2-methyl-3-hydroxybutyric acid level; and very common findings: Vomiting, Acidosis, Metabolic acidosis, and Fever and others. 46 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 12 | Intellectual disability, Lack of interest or motivation (apathy), Excessive daytime somnolence |
Digestive system | 4 | Vomiting, Diarrhea, Anorexia |
Metabolism | 3 | Metabolic acidosis, Fever, Abnormal metabolic brain imaging by MRS |
Blood and immune system | 2 | Elevated platelet count (thrombocytosis), Elevated white blood cell count (increased total leukocyte count) |
Kidneys and urinary system | 1 | Elevated urinary 2-methyl-3-hydroxybutyric acid level |
Cognition | 1 | Abnormality of mental function |
Heart and blood vessels | 1 | Hypertension |
Muscles | 1 | Low muscle tone (hypotonia) |
Growth and development | 1 | Weight loss |
Lab test results | 1 | Increased circulating lactate concentration |
ACAT1 encodes acetyl-CoA acetyltransferase 1 (427 aa). This is one of the enzymes that catalyzes the last step of the mitochondrial beta-oxidation pathway, an aerobic process breaking down fatty acids into acetyl-CoA. Highest expression in Liver (126.7 TPM) and Muscle Skeletal (97.7 TPM).
Beta-ketothiolase deficiency is caused by mutations in the ACAT1 gene on chromosome 11.
The ACAT1 protein participates in N158D ACAT1(35-427), G183R ACAT1(35-427), and N93S ACAT1(35-427) pathways.
ACAT1 is classified as a druggable target (Enzyme category) with score 2.5.
224 pathogenic variants reported in ACAT1 in ClinVar, including hotspot variants LRG_1400p1:p.Asn375Ser (2-star review) and LRG_1400p1:p.Met193Arg (2-star review).
Variant | Significance | Review Stars | Hotspot |
|---|---|---|---|
LRG_1400p1:p.Asn375Ser | Pathogenic/Likely pathogenic | 2 stars | Yes |
LRG_1400p1:p.Met193Arg | Pathogenic/Likely pathogenic | 2 stars | Yes |
LRG_1400p1:p.Ile387Thr | Pathogenic/Likely pathogenic | 2 stars | Yes |
LRG_1400p1:p.Gly152Ala | Pathogenic/Likely pathogenic | 2 stars | Yes |
LRG_1400p1:p.Thr297Met | Pathogenic/Likely pathogenic | 2 stars | Yes |
Genetic testing for ACAT1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for beta-ketothiolase deficiency has been reported in the published literature.
Phenotype severity distribution: 1 always present feature, 8 very common features, 11 common features.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
13 publications have been identified in PubMed for beta-ketothiolase deficiency. Research spans Case Report / Case Series (54%), Diagnostic / Biomarker (23%), and Review / Meta-Analysis (8%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 54% |
Testing and diagnosis research | 3 | 23% |
Research summaries | 1 | 8% |
Clinical study results | 1 | 8% |
Laboratory research | 1 | 8% |
Wang L (2026). [PMID: 41986274](https://pubmed.ncbi.nlm.nih.gov/41986274/). *Zhonghua Er Ke Za Zhi*. [Case Report / Case Series]
Jin JL (2026). [PMID: 41639795](https://pubmed.ncbi.nlm.nih.gov/41639795/). *BMC pediatrics*. [Diagnostic / Biomarker]
Vasco A (2025). [PMID: 40981306](https://pubmed.ncbi.nlm.nih.gov/40981306/). *International journal of neonatal screening*. [Case Report / Case Series]
Campos-Acevedo LD (2025). [PMID: 41283373](https://pubmed.ncbi.nlm.nih.gov/41283373/). *Pediatric reports*. [Case Report / Case Series]
Dweikat IM (2025). [PMID: 40598206](https://pubmed.ncbi.nlm.nih.gov/40598206/). *BMC medical genomics*. [Case Report / Case Series]
Duque Lasio ML (2025). [PMID: 40479756](https://pubmed.ncbi.nlm.nih.gov/40479756/). *Molecular genetics and metabolism*. [Diagnostic / Biomarker]
Al-Sawadi I (2025). [PMID: 41180774](https://pubmed.ncbi.nlm.nih.gov/41180774/). *Annals of medicine and surgery (2012)*. [Basic Science / Preclinical]
Li X (2025). [PMID: 39582021](https://pubmed.ncbi.nlm.nih.gov/39582021/). *Journal of human genetics*. [Clinical Trial Publication]
Zhen XM (2024). [PMID: 38853254](https://pubmed.ncbi.nlm.nih.gov/38853254/). *Clinical diabetes and endocrinology*. [Case Report / Case Series]
Nelson AT (2024). [PMID: 38788890](https://pubmed.ncbi.nlm.nih.gov/38788890/). *Clinica chimica acta; international journal of clinical chemistry*. [Diagnostic / Biomarker]
Data assembled from 9 of 12 sources · Last updated Oct 3, 2026, 8:10 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
AI-curated news mentioning beta-ketothiolase deficiency
Updated Aug 19, 2026
A recent study identifies two novel ACAT1 gene variants associated with beta-ketothiolase deficiency, based on a retrospective analysis of 76 cases in China. This research enhances understanding of the genetic underpinnings of this rare metabolic disorder.
A case report details beta-ketothiolase deficiency in a pediatric patient, highlighting progressive basal ganglia and extra basal ganglia involvement. The study correlates CT and MRI findings, contributing to the understanding of this metabolic encephalopathy.